Picture of Genus logo

GNS — Genus Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Genus, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line36.731.82.419.3286
Depreciation
Amortisation
Non-Cash Items3.315.630.731.4-207
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-44.7-40.6-50.2-28.2-45.2
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities34.350.429.867.274.4
Capital Expenditures-65.4-35.2-24.7-18.6-18.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1.84.35.44.8116
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-67.2-30.9-19.3-13.897.8
Financing Cash Flow Items-0.7-1.2—-6-3.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities21.9-18.2-2.8-46.6-178
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-7.2-2.56.25.5-4.3